PATENT CLAIM ANALYSIS

Application Number: 16132270
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["435", "061000"]

Abstract:
The present disclosure provides diagnostic methods useful for predicting a patient's response to alvocidib and guiding a physician decision to administer alvocidib to the patient.

Claim (Index 42):
The method of  claim 33  wherein the AML is relapsed or refractory.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.22727
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15134051', '16023360', '15033810', '15847697', '14713379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5883275757888646
- 35 USC 102 Novelty (BERT): 0.5814027914681605
- Combined Prediction Score: 0.5876350973567943
- Mean Citation Score: 366.452328
- Max Citation Score: 739.6235
- Similarity Product: 373.20514848095183

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test